Patent · US Expired

Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines

US6440968B1 · kind B1 · utility

0Cited by

0References

7Claims

0Family size

Assignee

elbion GmbH · DE

Inventors

Regina Draheim · Radebeul, DE
Thomas Kronbach · Radebeul, DE
Lothar Heinisch · Jena, DE
Ernst Roemer · Jena, DE
Norbert Höfgen · Radeberg, DE
Hildegard Poppe · Dresden, DE
Peter Jütten · Jena, DE
Wolfgang Haas · Germering, DE
Walter Werner · Jena, DE
Udo Grafe · Jena, DE

Key dates

Filing date	Apr 13, 2000
Grant date	Aug 27, 2002
Priority date	—
Expiry date	Apr 13, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The maduraphthalazine derivatives of the formula (4) are able to inhibit the effect of the cytokines interleukin-2, interleukin-4 and interleukin-5 and are suitable for the production of pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.